Cite
HARVARD Citation
Jabbour, E. et al. (2022). Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial. Lancet. 9 (12), pp. e878-e885. [Online].